Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
10.21
-0.20 (-1.92%)
At close: Oct 8, 2026, 4:00 PM EDT
10.15
-0.06 (-0.59%)
After-hours: Oct 8, 2026, 7:30 PM EDT
Corvus Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Reiterates $30 | Buy | Reiterates | $30 | +193.83% | Aug 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $27 | Buy | Maintains | $27 | +164.45% | Aug 10, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $33 | Buy | Reiterates | $33 | +223.21% | Aug 7, 2026 |
| Barclays | Barclays | Buy Maintains $28 | Buy | Maintains | $28 | +174.24% | Aug 7, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $40 | Buy | Maintains | $40 | +291.77% | May 15, 2026 |